CRSP CRISPR Therapeutics AG

NASDAQ
$39.10

CRISPR Therapeutics AG (CRSP) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with CRSP's own trailing one-year pace, with 30% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
4
7 transactions
Purchases
$0
0 shares
Sales
$4.9M
93,558 shares
Net activity
-$4.9M
purchases less sales

How much of that selling was preplanned? 30% planned / 70% discretionary

10b5-1 plan sales $1.5M 3 transactions · 26,904 shares
Discretionary sales $3.4M 4 transactions · 66,654 shares

Largest single sale: $2.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: April 3, 2025 — 1.6 years ago, by Patel Naimish .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kulkarni Samarth Chief Executive Officer Sell 47,837 $49.78 $2.4M 311,899 −13.3% of holding
George Simeon Director Sell 10b5-1 14,514 $49.63 $720.4K 15,486 −48.4% of holding
Kulkarni Samarth Chief Executive Officer Sell 4,098 $49.26 $201.9K 259,736 −1.6% of holding
KASINGER JAMES R. General Counsel and Secretary Sell 1,040 $49.26 $51.2K 95,857 −1.1% of holding
KASINGER JAMES R. General Counsel and Secretary Sell 10b5-1 1,990 $60.04 $119.5K 94,784 −2.1% of holding
KASINGER JAMES R. General Counsel and Secretary Sell 10b5-1 10,400 $60.24 $626.5K 94,784 −9.9% of holding
Behbahani Ali Director Sell 13,679 $57.09 $780.9K 16,637 −45.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.